Early research (Phase 1)Ended earlyNCT01832974What this trial is testingPossible New Therapy for Advanced CancerWho this might be right forAdrenocortical Carcinoma INSYS Therapeutics Inc 9
Testing effectiveness (Phase 2)UnknownNCT03612232What this trial is testingCabozantinib in Advanced Adrenocortical CarcinomaWho this might be right forAdrenocortical Carcinoma Wuerzburg University Hospital 37
Early research (Phase 1)Looking for participantsNCT07189403What this trial is testingDS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate CancerWho this might be right forAdvanced or Metastatic Adrenocortical CarcinomaMetastatic Castration-resistant Prostate Cancer Daiichi Sankyo 40
Early research (Phase 1)Study completedNCT01772004What this trial is testingAvelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)Who this might be right forSolid Tumors EMD Serono Research & Development Institute, Inc. 1,756
Early research (Phase 1)Looking for participantsNCT04119024What this trial is testingGene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsWho this might be right forMetastatic Malignant Solid NeoplasmMetastatic MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+14 more Anusha Kalbasi 18
Testing effectiveness (Phase 2)Study completedNCT01255137What this trial is testingPhase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-Pathway in Metastatic, Recurrent or Primary Unresectable Adrenocortical CancerWho this might be right forAdrenal Cortex Neoplasms National Cancer Institute (NCI) 13
Early research (Phase 1)Study completedNCT00004074What this trial is testingInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuWho this might be right forAdvanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Looking for participantsNCT06333314What this trial is testingDostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSIWho this might be right forPancreatic AdenocarcinomaAmpulla of Vater CarcinomaAdrenocortical Carcinoma+5 more UNICANCER 120
Testing effectiveness (Phase 2)Ended earlyNCT05012397What this trial is testingMilademetan in Advanced/Metastatic Solid TumorsWho this might be right forSolid TumorsHead and Neck CarcinomaCholangiocarcinoma+15 more Rain Oncology Inc 40
Testing effectiveness (Phase 2)Ended earlyNCT00002921What this trial is testingS9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by SurgeryWho this might be right forAdrenocortical Carcinoma SWOG Cancer Research Network 13
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Ended earlyNCT03145909What this trial is testingA Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)Who this might be right forAdvanced Solid Tumors Cancer AbbVie 19
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT01514526What this trial is testingClinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical CarcinomaWho this might be right forAdrenocortical Carcinoma Spanish Oncology Genito-Urinary Group 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013What this trial is testingNivolumab and Ipilimumab in Treating Patients With Rare TumorsWho this might be right forAcinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more National Cancer Institute (NCI) 818
Very early researchStudy completedNCT00436410What this trial is testingTumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic CancerWho this might be right forAdrenocortical CarcinomaBreast CancerColorectal Cancer+7 more National Institutes of Health Clinical Center (CC) 108
Testing effectiveness (Phase 2)Study completedNCT00848016What this trial is testingGossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By SurgeryWho this might be right forRecurrent Adrenocortical CarcinomaStage III Adrenocortical CarcinomaStage IV Adrenocortical Carcinoma National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)Looking for participantsNCT06006013What this trial is testingCabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical CancerWho this might be right forLocally Advanced Adrenal Cortex CarcinomaAdrenal Cortical CarcinomaStage III Adrenal Cortex Carcinoma+2 more Emory University 21
Large-scale testing (Phase 3)Study completedNCT00924989What this trial is testingOSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical CarcinomaWho this might be right forAdrenocortical Carcinoma Astellas Pharma Inc 139
Not applicableLooking for participantsNCT06050057What this trial is testingSurgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted AdrenalectomyWho this might be right forAdrenal TumorAdrenal DiseaseAdrenal Mass+10 more University Hospital Olomouc 100